Depressive symptomatology, medication persistence, and associated healthcare costs in older adults with glaucoma

Journal of Glaucoma

Volumn 16, Issue 6, 2007, Pages 513-520

  Jayawant, Sujata S ^a   Bhosle, Monali J ^a   Anderson, Roger T ^b   Balkrishnan, Rajesh ^a  

^a OHIO STATE UNIVERSITY   (United States)

^b WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

Depressive symptoms; Elderly; Glaucoma; Healthcare costs; Persistence

Indexed keywords

ANTIGLAUCOMA AGENT;

AGED; ARTICLE; CENTER FOR EPIDEMIOLOGICAL STUDIES DEPRESSION SCALE; COMORBIDITY; DEMOGRAPHY; DEPRESSION; DISEASE ASSOCIATION; ELDERLY CARE; FEMALE; HEALTH CARE COST; HEALTH CARE UTILIZATION; HEALTH MAINTENANCE ORGANIZATION; HUMAN; LIFESTYLE; MAJOR CLINICAL STUDY; MALE; OPEN ANGLE GLAUCOMA; PATIENT COMPLIANCE; PRESCRIPTION; PRIORITY JOURNAL; QUALITY OF LIFE; RISK ASSESSMENT; THEORETICAL MODEL; TREATMENT OUTCOME;

AGED; AGED, 80 AND OVER; ANTIHYPERTENSIVE AGENTS; DEPRESSIVE DISORDER; DRUG UTILIZATION; FEMALE; GLAUCOMA, OPEN-ANGLE; HEALTH CARE COSTS; HEALTH MAINTENANCE ORGANIZATIONS; HEALTH SERVICES; HEALTH SERVICES RESEARCH; HUMANS; MALE; PATIENT COMPLIANCE; PRESCRIPTIONS, DRUG; RETROSPECTIVE STUDIES;

EID: 34548700823     PISSN: 10570829     EISSN: None     Source Type: Journal    
DOI: 10.1097/IJG.0b013e31804a5ec6     Document Type: Article

References (49)

1. Coleman AL. Glaucoma. Lancet. 1999;354:1803-1810.
2. Infeld DA, O'Shea JG. Glaucoma: diagnosis and management. Postgrad Med J. 1998;74:709-715.
3. Prevent Blindness America. Available at: http://www.preventblindness.org/ Accessed October 1, 2006.
4. The Eye Diseases Prevalence Research Group. Prevalence of open-angle glaucoma among adults in the United States. Arch Ophthalmol. 2004;122:532-538.
5. American Academy of Ophthalmology. Available at: http://www.aao.org/ Accessed October 1, 2006.
6. National Institutes of Health. Available at: http://www.nei.nih.gov/ Accessed October 1, 2006.
7. Sommer A, Tielsch JM, Katz J, et al. Racial differences in the causes-pecific prevalence of blindness in East Baltimore. N Engl J Med. 1991;325:1412-1417.
8. Gutierrez P, Wilson MR, Johnson C, et al. Influence of glaucomatous visual field loss on health-related quality of life. Arch Ophthalmol. 1997;115:777-784.
9. Quigley HA, Vitale S. Models of glaucoma prevalence and incidence in the United States. Invest Ophthalmol Vis Sci. 1997;38:83-91.
10. Friedman DS, Nordstorm B, Mozaffari E, et al. Variations in treatment among adult-onset open-angle glaucoma patients. Ophthalmology. 2002;112:1494-1499.
11. Aran Eye Associates. Available at http://www.araneyeassociates.com/ patient-info.html Accessed December 1, 2006.
12. Nordstrom BL, Friedman DS, Mozaffari E, et al. Persistence and adherence with topical glaucoma therapy. Am J Ophthalmol. 2005;140:598-606.
13. DeMatteo MR. Variations in patients' adherence to medical recommendations: a quantitative review of 50 years of research. Med Care. 2004;42:200-209.
14. Wilensky J, Fiscella R, Carlson A, et al. Measurement of persistence and adherence to regimens of IOP-lowering glaucoma medications using pharmacy claims data. Am J Ophthalmol. 2006;141:S28-S33.
15. Heijl A, Leske MC, Bengtsson B, et al. Early Manifest Glaucoma Trial Group. Reduction of intraocular pressure and Glaucoma progression: results from the Early Manifest Glaucoma Trial. Arch Ophthalmol. 2002;120:1268-1279.
16. Gurwitz JH, Glynn RJ, Monane M, et al. Treatment for glaucoma: adherence for the elderly. Am J Public Health. 1993;83:711-716.
17. Dasgupta S, Oates V, Bookhart BK, et al. Population-based persistency rates for topical glaucoma medications measured with pharmacy claims data. Am J Manag Care. 2002;8(suppl 10):S255-S261.
18. Spooner JJ, Bullano MF, Ikeda LI, et al. Rates of discontinuation and change of glaucoma therapy in a managed care setting. Am J Manag Care. 2002;8(suppl 10):S262-S270.
19. Shaya FT, Mullins CD, Wong W, et al. Discontinuation rates of topical glaucoma medications in a managed care population. Am J Manag Care. 2002;8(suppl 10):S271-S277.
20. Schwartz GF, Reardon G, Mozafari E. Persistency with latanoprost or timolol in primary open-angle glaucoma suspects. Am J Manag Care. 2004;137(suppl 1):S3-S12.
21. Reardon G, Schwartz GF, Mozafari E. Patient persistency with topical ocular hypotensive therapy in a managed care population. Am J Manag Care. 2004;137(suppl 1):S13-S16.
22. Raj A. Depression in elderly. Tailoring medication therapy to their special needs. Postgrad Med. 2004;115:26-28.
23. Balkrishnan R, Rajagopalan R, Camacho FT, et al. Predictors of medication adherence and associated health care costs in an older population with type 2 diabetes mellitus: a longitudinal cohort study. Clin Ther. 2003;25:2958.
24. Balkrishnan R, Bhosle MJ, Camacho FT, et al. Predictors of medication adherence and associated health care costs in an older population with overactive bladder syndrome: a longitudinal study. J Urol. 2006;175:1067-1072.
25. Balkrishnan R, Christensen DB, Bowton DL. Self-reported health status, prophylactic medication use, and healthcare costs in older adults with asthma. J Am Geriatr Soc. 2004;50:924-929.
26. Kulkarni AS, Balkrishnan R, Camacho FT, et al. Medication and health care service utilization related to depressive symptoms in older adults with psoriasis. J Drugs Dermatol. 2004;3:661-666.
27. Glick H, Brainsky A, McDonald RC et al. The cost of glaucoma in the United States in 1988. Chibret Int J Ophthalmol. 1994;10:6-12.
28. Lee PP, Walt JG, Doyle JJ, et al. A multicenter, retrospective pilot study of resource use and costs associated with severity of disease in glaucoma. Arch Ophthalmol. 2006;124:12-19.
29. Kobelt-Nguyen G, Gerdtham UG, Alm A. Costs of treating primary open angle glaucoma and ocular hypertension: a retrospective, observational two-year chart review of newly diagnosed patients in Sweden and the United States. J Glaucoma. 1998;7:95-104.
30. Rotchford AP, Murphy KM. Compliance with timolol treatment in glaucoma. Eye. 1998;12:234-236.
31. Patel SC, Spaeth GL. Compliance in patients prescribed eyedrops for glaucoma. Ophthalmic Surg. 1995;26:233-236.
32. International Classification of Diseases. Clinical Modification. 9th revision, Los Angeles, CA: Practice Management Information Corporation; 1995.
33. Lawton MP, Brody EM. Assessment of older people: self-maintaining and instrumental activities of daily living. Gerontologist. 1969;9:79-86.
34. Ware J Jr, Kosinski M, Keller SD. A 12-item Short-Form health Survey: construction of scales and preliminary tests of reliability and validity. Med Care. 1996;34:220-233.
35. Mulrow CD, Williams JW Jr, Gerety MB, et al. Case-finding instruments for depression in primary care settings. Arch Intern Med. 1995;122:913-921.
36. Markush RE, Favero RV. Epidemiologic assessment of stressful life events, depressed mood, and psychophysiological symptoms: a preliminary report. In: Dohrenwend BS, Dohrenwend BP, eds. Stressful Life Events: Their Nature and Effects. New York: John Wiley & Sons; 1973.
37. Radloff LS. The CES-D scale: a self-report depression scale for research in the general population. Appl Psychol Meas. 1977;1:385.
38. Charlson ME, Pompei P, Ales KL, et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chron Dis. 1998;40:372-383.
39. Balkrishnan R, Byerly WC, Camacho FT, et al. Effect of prescription benefit changes on medical care utilization in a medicare HMO population. Am J Manag Care. 2001;7:1093-1100.
40. Choo PW, Rand CS, Inui TS, et al. Validation of patient reports, automated pharmacy records, and pill counts with electronic monitoring of adherence to antihypertensive therapy. Med Care. 1999;37:846-857.
41. Balkrishnan R, Anderson RT. Predictive power of a risk-assessment questionnaire across different disease states: results in an elderly managed care enrolled population. Am J Manag Care. 2001;7:145-153.
42. Halvorsen R, Palmquist R. The interpretation of dummy variables in semilogarithmic equations. Am Econ Rev. 1980;70:474-475.
43. Kennedy P. Estimation with correctly interpreted dummy variables in semilogarithmic equations. Am Econ Rev. 1981;71:801.
44. STATA Statistical Software. Release 9.0. 2000; STATA Corporation, College Station, TX.
45. Kosoko O, Quigley HA, Vitale S, et al. Risk factors for noncompliance with glaucoma follow-up visits in a residents' eye clinic. Ophthalmology. 1998;105:2105-2111.
46. Tsai JC. Medication adherence in glaucoma: approaches for optimizing patient compliance. Curr Opin Ophthalmol. 2006;17:190-195.
47. Beers MH, Baran RW, Frenia K. Drugs and elderly, part I: the problems facing managed care. Am J Manag Care. 2000;6:1313-1320.
48. Moss JK, Steiner K, Mahnke K, et al. A model to manage capitated risks. Nurs Econ. 1998;16:65-68.
49. Wilson MR, Coleman AL, Yu F, et al. Depression in patients with glaucoma as measured by self-report surveys. Opthalmology. 2002;109:1018-1022.